Home/Filings/4/0000950170-24-057451
4//SEC Filing

Lenk Robert P 4

Accession 0000950170-24-057451

CIK 0001095981other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 7:30 AM ET

Size

7.2 KB

Accession

0000950170-24-057451

Insider Transaction Report

Form 4
Period: 2024-05-08
Transactions
  • Purchase

    Common Stock

    2024-05-08$2.04/sh+4,167$8,50129,327 total
  • Award

    Warrants (Right to buy)

    2024-05-08+8,3348,334 total
    Exercise: $1.79From: 2024-05-08Common Stock Warrants (8,334 underlying)
Footnotes (2)
  • [F1]The expiration date for 4,167 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,167 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.
  • [F2]Half of the warrants are Series A warrants and the other half are Series B warrants.

Documents

1 file

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1
  • filerCIK 0001362635

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 7:30 AM ET
Size
7.2 KB